Trial intelligence / Profile preview

STIM trial: ovarian stimulation protocols in women with breast cancer undergoing fertility preservation

2013-000801-21Phase 3Active

Sponsor
Academic Medical Center
Start
Aug 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of letrozole and tamoxifen in breast cancer (3 arms), sponsored by Academic Medical Center. Primary endpoint: Number of oocytes retrieved at follicle aspiration. Started Aug 2013; status: active.

02

Drugs

letrozoletamoxifen
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2013-000801-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000801-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call